https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/s-ad-leq-treatment-received-patient-information-video/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-sahashi-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/s-ad-leqmbi-mechanism-of-action/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/evaluation-tools/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-takahashi-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/120-year-journey-of-alzheimer-disease-research/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/shared-decision-making/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/evaluation-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/s-ad-dr-iwata-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/treatment-support/intrathecal-injection-of-qalsody/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/events/ad-events/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ms/guideline/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/patient-supports/sma-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/patient-supports/ms-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/tecfidera/drug-information/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/events/sma-events/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/events/als-events/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/vip-site-registration/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/case-report/dr-nagano-03/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/case-report/dr-nagano-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/case-report/dr-nagano-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/case-report/dr-nagano-dr-nagashima-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/case-report/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-yutaka-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-yonekawa-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/leqembi/request-for-proper/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/rulm/eval-rulmvideo/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/hfmse/hfmse-video/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/chop-intend/chop-intend-video/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/diagnostic-support/genetic-counseling/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/diagnostic-support/genetic-counseling-dr-aoki/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ms/expert-lecture/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/akamai-reset-password/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/tof-special-page/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-funado-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-yoshioka-01-dr-katayama-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-sazuo-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-shimomura-and-dr-tokunaga-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-shimomura-dr-tokunaga-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/events/ms-events/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/patient-supports/common-diseases/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ms/product-content/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/terms-conditions/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/latest-info/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/faq/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/qalsody/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/tysabri/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/tysabri/risk03/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/tysabri/risk01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/tysabri/safety02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/tysabri/safety01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/tysabri/seizai/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/avonex/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/tecfidera/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/leqembi/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/eisai-redirect/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-nakamura-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-yuge-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/treatment-support-content/evolving-sma-treatment-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/treatment-support-content/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/treatment-support-content/sma-respiratory-care-articles/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ms/expert-lecture/dr-fujihara-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/lumbar-puncture-simulation-video/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/s-ad-detect-mci-earlier-video02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/s-ad-detect-mci-earlier-video01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/events/sma-events/sma-event-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/administration-of-spinraza/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/ultrasound-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/dose-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/administration-in-adult-cases/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/spinraza/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/top-intrathecal-administration/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/devote-clinical-trial/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-kakimoto-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/spinraza-administration-support-video/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/intrathecal-administration/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/xray-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/dose-manual/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/expert-manual/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/spinraza-admin-video/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/spinraza-administer/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ms/patient-materials/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/explanatory-video/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/atend/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/skeletal-muscle-CT-image/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/definite-diagnosis-age60/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/definite-diagnosis-age30/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-ishigaki-03/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-ishigaki-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-maruyama-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-definite-diagnosis/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/definite-diagnosis-age2/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-minamino-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-minamino-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-watanabe-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-okubo-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/case-report-pediatric/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-shiraishi-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-kimizu-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-yamamoto-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-ryosuke-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-watanabe-03/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-watanabe-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-kimoto-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-tominaga-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-yamamoto-dr-fuyama-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-kimizu-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-omata-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-nakajima-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-okazaki-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-fukuda-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-fukuda-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-yokoyama-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-tozawa-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-hayakawa-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-kira-dr-ueno-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/diagnostic-support/d-als-dr-atsuta-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/patient-materials/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/what-are-the-priorities-for-dementia-research/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/events/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/treatment-support/qalsody-treatment-system/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/screening-for-early-cognitive-impairment-rapid-changes-ahead/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-kobayashi-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/qalsody/about-sod1-als/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/diagnostic-support/d-als-dr-izumi/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/s-ad-dr-mimura-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/s-ad-understanding-mci/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/s-ad-mci-disease-awareness/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/treatment-support/s-ad-explanation-for-radiologists/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/diagnostic-support/genetic/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/treatment-support/clinical-trials-and-safety-of-qalsody/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-ishigaki-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ms/cog-eval/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ms/case-report/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-sahashi-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/treatment-support/mechanism-of-action-of-qalsody/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/treatment-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/inside-als/diagnostic-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ms/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/key-points-for-sma-diagnosis/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-kimizu-05/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-kimizu-04/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/safety-information/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ad/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/mechanism-of-action/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/safety-and-efficacy/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/presymptomatic-sma/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-ryosuke-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-nbs-key-points/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-nbs-ehime-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-nbs-nagano-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/library/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/case-report-adult/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-ayaki-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-ayaki-03/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-takasone-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-saitou-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-kishida-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-iwayama-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-iwayama-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-ayaki-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-saitou-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-ayaki-04/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-iwayama-03/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/cookies/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-nbs-tochigi-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/bookmark/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/evaluation-tool/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/safety-info/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/efficacy-typeII-III/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ms/ms-monthly-update/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/leqembi/safety01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/contact/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/dr-tozawa-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/treatment-info-website/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/pat-ic-support-video/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/other-evaluation-scale/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/efficacy-typeI/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/clinical-trial/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/case-report/case-report-infant/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-nbs-kumamoto-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-nbs-osaka-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-nbs-gifu-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/rehabilitation-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/hcp-ic-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/pat-ic-support/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/rulm/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/hfmse/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/evaluation-support/chop-intend/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/tecfidera/seizai/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/avonex/seizai/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/avonex/safety/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/patient-supports/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/tisma/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/tisma/about-sma/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/tisma/sma-symptoms/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/tisma/sma-diagnosis/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/tisma/scoliosis-surgery/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/tisma/sma-care/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/tisma/nutrition/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/tisma/respiratory/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/tisma/resources/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/treatment-support/spinraza-mechanism/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/about-sma/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-disease-mechanism/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-natural-history/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-symptoms/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-causes-diagnosis/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/sma-treatment-care/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/genetic-testing/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/similar-disease-01/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/diagnostic-support/similar-disease-02/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/spinraza/about-dosing/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/products/ 2026-04-03T22:52:03.070Z monthly 1.0 https://biogenlinc.jp/ja/therapeutics/sma/emsl/ 2026-04-03T22:52:03.070Z monthly 1.0